Defining and treating leucine-rich glioma inactivated 1 antibody associated autoimmunity.
Department of Clinical Neurosciences, Addenbrooke's Hospital, Cambridge, UK.
Michael S
MS
Zandi
D000906:Antibodies / Q000627:therapeutic use*; D003072:Cognition Disorders / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008297:Male; D012640:Seizures / Q000188:drug therapy*
D000906:Antibodies